FP7H2020
Oncomark Limited
- Country
- IEIreland
- Defence projects
- 0
- Projects, all programmes
- 10
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 7,779,015
- Active
- 2009 to 2016
Projects
10 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| OncoMasTROncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer | H2020 | 2016 | Coordinator | EUR 2,751,250 |
| TOPMed10Fellowship Programme supporting Career Development and Interdisciplinary Training in Omics driven Personalised Medicine | H2020 | 2015 | Partner | EUR 0 |
| MEL-PLEXExploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine | H2020 | 2014 | Participant | EUR 265,675 |
| SYS-MELSYSTEMS-BASED VIEW OF MELANOMA PROGRESSION: TOWARDS NOVEL DIAGNOSTIC (AND THERAPEUTIC) APPLICATIONS | FP7 | 2013 | Participant | EUR 737,861 |
| APO-DECIDEApoptosis Modelling for Treatment Decisions in Colorectal Cancer | FP7 | 2012 | Participant | EUR 508,000 |
| ANGIOPREDICTPredictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer | FP7 | 2012 | Participant | EUR 697,800 |
| RATHERRational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes | FP7 | 2011 | Participant | EUR 995,520 |
| FAST-PATHFast-Tracking Pathology via Automated Image Analysis and High-Performance Computing: Application to Prostate Cancer Diagnostics | FP7 | 2011 | Participant | EUR 534,359 |
| ANGIOTOXHistopathologic and Mechanistic Assessment of Angiogenesis Inhibitor Related Toxicities: A Cross-Sectoral, Multi-disciplinary Approach | FP7 | 2010 | Participant | EUR 493,891 |
| TARGET-MELANOMAMolecular Dissection of Melanoma Progression: An integrated Pan-European Approach | FP7 | 2009 | Participant | EUR 794,659 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.